Catalyst Wire Dossier Catalyst Wire Dossier

AUSTEDO XR

deutetrabenazine · Teva Neuroscience, Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for AUSTEDO XR, covering 2023-02-17 to 2025-02-28. Get the full timeline:

Most recent: FDA Approved: AUSTEDO XR — Supplemental Application (Teva Neuroscience, Inc.)

See pricing